Gene · 26524
Papers2,966
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,966
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncRNA HOTAIRM1 Inhibits the Proliferation and Invasion of Lung Adenocarcinoma Cells via the miR-498/WWOX Axis [Retraction]. | Cancer Manag Res | 2024 | 38282791 | PubTator, text mining | PubMed |
| KLF15 transcriptionally activates LINC00689 to inhibit colorectal cancer development. | Commun Biol | 2024 | 38273088 | PubTator, text mining | PubMed |
| Inactivation of MST1/2 Controls Macrophage Polarization to Affect Macrophage-Related Disease via YAP and Non-YAP Mechanisms. | Int J Biol Sci | 2024 | 38250155 | PubTator, text mining | PubMed |
| The LKB1-TSSK1B axis controls YAP phosphorylation to regulate the Hippo-YAP pathway. | Cell Death Dis | 2024 | 38245531 | PubTator, text mining | PubMed |
| Tumor-derived small extracellular vesicles in cancer invasion and metastasis: molecular mechanisms, and clinical significance. | Mol Cancer | 2024 | 38243280 | PubTator, text mining | PubMed |
| Relationship between long non-coding RNAs and Hippo signaling pathway in gastrointestinal cancers; molecular mechanisms and clinical significance. | Heliyon | 2024 | 38226210 | PubTator, text mining | PubMed |
| LATS2 condensates organize signalosomes for Hippo pathway signal transduction. | Nat Chem Biol | 2024 | 38200110 | PubTator, text mining | PubMed |
| Unveiling the mechanistic link between extracellular amyloid fibrils, mechano-signaling and YAP activation in cancer. | Cell Death Dis | 2024 | 38199984 | PubTator, text mining | PubMed |
| Uncovering hidden cancer self-dependencies through analysis of shRNA-level dependency scores. | Sci Rep | 2024 | 38195844 | PubTator, text mining | PubMed |
| Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways. | Biomark Res | 2024 | 38191508 | PubTator, text mining | PubMed |
| Exosomal microRNA-Based therapies for skin diseases. | Regen Ther | 2024 | 38178928 | PubTator, text mining | PubMed |
| Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets. | Signal Transduct Target Ther | 2024 | 38169461 | PubTator, text mining | PubMed |
| Characterization of dabrafenib-induced drug insensitivity via cellular barcoding and collateral sensitivity to second-line therapeutics. | Sci Rep | 2024 | 38167959 | PubTator, text mining | PubMed |
| GPR137 inactivates Hippo signaling to promote gastric cancer cell malignancy. | Biol Direct | 2024 | 38163861 | PubTator, text mining | PubMed |
| miR-155-5p/Bmal1 Modulates the Senescence and Osteogenic Differentiation of Mouse BMSCs through the Hippo Signaling Pathway. | Stem Cell Rev Rep | 2024 | 38150082 | PubTator, text mining | PubMed |
| Sirtuin 5-mediated deacetylation of TAZ at K54 promotes melanoma development. | Cell Oncol (Dordr) | 2024 | 38112979 | PubTator, text mining | PubMed |
| Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer. | Transl Oncol | 2024 | 38042134 | PubTator, text mining | PubMed |
| Exosomes derived from adipose tissues accelerate fibroblasts and keratinocytes proliferation and cutaneous wound healing via miR-92a/Hippo-YAP axis. | J Physiol Biochem | 2024 | 38041784 | PubTator, text mining | PubMed |
| Palbociclib sensitizes ER-positive breast cancer cells to fulvestrant by promoting the ubiquitin-mediated degradation of ER-α via SNHG17/Hippo-YAP axis. | Breast Cancer Res Treat | 2024 | 37924380 | PubTator, text mining | PubMed |
| Ferroptosis: a potential therapeutic target for stroke. | Neural Regen Res | 2024 | 37862200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26524/papers?page=7